🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver and Intrahepatic Biliary Tract Cancer

Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation NCT06718153NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Immunohistochemistry and in situ hybridisation analysis Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention NCT07010315n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Cognitive Testing, Usability Testing Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site📍 Shanghai RenJi Hospital · Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology NCT07303725n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer NCT07174570Phase 24 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Celecoxib, Durvalumab, Tremelimumab, Biospecimen Collection, Computed Tomography Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307Phase 21 site📍 Palo Alto Stanford University · Tests: MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant NCT06725121Phase 1, Phase 22 sites📍 London📍 Toronto University Health Network, Toronto · Tests: Atezolizumab & Bevacizumab, Yttrium-90 (Y-90), Stereotactic body radiotherapy (SBRT) AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site📍 Shanghai Guo ShiWei · Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer NCT07884877Phase 21 site📍 Seoul Samsung Medical Center · Tests: PULSAR (Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy), Immune checkpoint inhibitor-based therapy EGCG for Hepatocellular Carcinoma Chemoprevention NCT06015022Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Epigallocatechin gallate (EGCG), Placebo Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer NCT07356531NA15 sites📍 Hefei📍 Beijing📍 Nanning JIANGSU SHENMING Medical Technology CO., Ltd · Tests: Transcatheter Arterial Chemoembolization Defining the Ablative Dose for Y-90 TARE NCT07586046Phase 21 site📍 Chicago Northwestern University · Tests: Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 Feasibility Study of CBCT for IGRT in Cancer Patients NCT06681233NA4 sites📍 Columbus📍 Columbus📍 Columbus Varian, a Siemens Healthineers Company · Tests: Comparison of HyperSight CBCT imaging to conventional CBCT imaging. Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy NCT06341270NA1 site📍 Chengdu West China Hospital · Tests: transcutaneous electrical acupoint stimulation, sham transcutaneous electrical acupoint stimulation Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis NCT06781242n/a2 sites📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna Collection of Blood From Patients With Cancer NCT00034216n/a1 site📍 Bethesda National Cancer Institute (NCI) Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action NCT06600295n/a1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: tests/questionnaires, biological samples, evaluation ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357Phase 1, Phase 24 sites📍 Los Angeles📍 Orange📍 San Francisco Eureka Therapeutics Inc. · Tests: ET140203 T Cells Combination of TATE and PD-1 Inhibitor in Liver Cancer NCT03259867Phase 23 sites📍 Orange📍 Oklahoma City📍 Milwaukee Teclison Ltd. · Tests: Nivolumab Injectable Product, Trans-arterial tirapazamine embolization A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) NCT07430202Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: DNAJB1-PRKACA Peptide Vaccine, DRP-104, Nivolumab, Ipilimumab Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer NCT05323201Phase 1, Phase 21 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors NCT06179602n/a1 site📍 Leiden Leiden University Medical Center Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site📍 Nanjing Nanjing Medical University The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study NCT07141056n/a5 sites📍 Zhanjiang📍 Guilin📍 Guilin Guilin Medical University, China · Tests: Psychological Stress Status, Psychological Stress Status, Psychological stress status
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy